This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Preliminary Evaluation of CASTLE Barrier Prototype UK

This study has been terminated.
(Inability of site to recruit/enroll target population)
Information provided by (Responsible Party):
Hollister Incorporated Identifier:
First received: February 7, 2012
Last updated: February 22, 2016
Last verified: September 2015
The purpose of this study is to provide preliminary assessment of the safety and performance of a novel barrier formulation (CASTLE) in a small population of subjects with irritated peristomal skin.

Condition Intervention
Peristomal Skin Complication Device: CASTLE barrier

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Peristomal Skin Irritation: A Preliminary Evaluation of the CASTLE Barrier Prototype for People With Intestinal Stomas

Further study details as provided by Hollister Incorporated:

Primary Outcome Measures:
  • Peristomal Skin Condition [ Time Frame: 1 - 30 days ]
    mean irritation score using a categorical scale with range of 1(normal) to 5(eroded or heaemorrhagic dermatitis)

Secondary Outcome Measures:
  • Security [ Time Frame: 30 days ]
    wear time leakage barrier erosion

Enrollment: 3
Study Start Date: January 2012
Study Completion Date: August 2012
Primary Completion Date: February 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Treatment
CASTLE Barrier
Device: CASTLE barrier
Prototype barrier to be used in place of current two piece device

Detailed Description:
This is a single-site, unblinded, historically controlled, first use in humans study of a stoma barrier with a new formulation. Approximately 34 subjects who are currently using a 2-piece tape bordered product and able and willing to wear a product will be enrolled. Each participant is provided with one box containing 20 of the test barriers to be used consecutively according to their normal routine. Each participant is also provided with a box containing 30 pouches selected to most closely resemble their current product. Participants are asked to record the time of application and time of removal of each test barrier and their assessment of relevant characteristics for each test barrier. A clinical evaluation of the peristomal skin is conducted at study entry, at approximately mid way through the study and again at its conclusion. Photographs are taken of the peristomal skin at each visit using a digital camera. Individual participation in terms of wearing the barrier is for 30 days or until the test barrier has been used up, whichever comes first. The study is comprised of 3 visits, an enrolment visit, a mid-study visit and a completion visit and a phone call at approximately day 7.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • at least 18 years of age
  • has colostomy or ileostomy
  • current uses two piece tape bordered barrier
  • has mild to moderate peristomal skin irritation
  • cares for their stoma independently in the community
  • at least 3 months post-operative
  • provides informed consent

Exclusion Criteria:

  • has fistula on or near stoma
  • has been involved in stoma care study in the last 30 days
  • is pregnant or lactating (determined by interview only)
  • has existing medical condition that would compromise their participation or follow-up
  • currently uses convex ostomy products, paste and/or rings
  • is allergic to test barrier components
  • is undergoing chemo- or radiotherapy that may affect the interpretation of the results
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01530087

United Kingdom
York Teaching Hospital
York, United Kingdom, YO31 8HE
Sponsors and Collaborators
Hollister Incorporated
Study Director: Richard Murahata, PhD Hollister Incorporated
  More Information

Responsible Party: Hollister Incorporated Identifier: NCT01530087     History of Changes
Other Study ID Numbers: 4518-O
CIV-GB-11-07-001241 ( Registry Identifier: Eudamed )
Study First Received: February 7, 2012
Results First Received: September 22, 2015
Last Updated: February 22, 2016

Keywords provided by Hollister Incorporated:
irritant dermatitis
two piece barrier processed this record on August 16, 2017